TTP Investments’s Pfizer PFE Stock Holding History

TTP Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-7,028	Closed	-$287K	–	47
2023 Q1	$287K	Sell	7,028 -80	-1%	-$3.46K	0.22%	30
2022 Q4	$364K	Sell	7,108 -163	-2%	-$7.82K	0.38%	26
2022 Q3	$318K	Sell	7,271 -124	-2%	-$6.03K	0.38%	23
2022 Q2	$388K	Buy	7,395 +681	+10%	+$34.7K	0.46%	21
2022 Q1	$348K	Sell	6,714 -37	-0.5%	-$1.92K	0.35%	18
2021 Q4	$399K	Buy	+6,751	New	+$334K	0.27%	21

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TTP Investments's PFE Position: Q2 2023 in Review

TTP Investments sold out of Pfizer (PFE) in Q2 2023, closing a stake of 7,028 shares — an estimated $287K sold.

TTP Investments first reported a position in PFE in Q4 2021 and held it in 6 quarters. The position peaked at $399K in Q4 2021. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.

TTP Investments reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
TTP Investments sold 7,028 Pfizer shares in Q2 2023, an estimated $287K.
TTP Investments first reported a position in Pfizer in Q4 2021 and held it in 6 quarters.
TTP Investments's Pfizer position peaked at $399K in Q4 2021.
3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.

Based on TTP Investments's 13F filing for Q2 2023, filed 25 Jul 2023.